Suppr超能文献

CHARISMA 随机对照试验:在南非约翰内斯堡,针对接受口服暴露前预防(PrEP)的女性,将以关系为重点的咨询干预整合到 PrEP 服务中,以预防艾滋病毒。

The CHARISMA Randomized Controlled Trial: A Relationship-Focused Counseling Intervention Integrated Within Oral PrEP Delivery for HIV Prevention Among Women in Johannesburg, South Africa.

机构信息

Women's Global Health Imperative, RTI International, Berkeley, CA.

Wits Reproductive Health and HIV Institute, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

J Acquir Immune Defic Syndr. 2022 Aug 1;90(4):425-433. doi: 10.1097/QAI.0000000000002991.

Abstract

BACKGROUND

Consistent use of oral pre-exposure prophylaxis (PrEP) has been a challenge among women, particularly when in relationships with lack of partner support or intimate partner violence (IPV).

METHODS

We conducted a randomized controlled trial (RCT) of an empowerment counseling intervention called "CHARISMA" delivered to women within a PrEP demonstration project in Johannesburg, South Africa. The trial tested the effectiveness of CHARISMA to increase PrEP adherence; decrease social harms and IPV; and improve partnership dynamics (eg, communication, disclosure and support) compared with those who received the standard of care counselling support and referrals. Four hundred seven HIV-seronegative, nonpregnant women aged 18-45 years were enrolled for 6 months of PrEP use, with 203 randomized (1:1) to the intervention. All participants reporting IPV received counseling and referrals that followed the WHO five-step Listen, Inquire, Validate, Enhance Safety, and Support approach.

RESULTS

This RCT did not identify statistically significant differences between study arms for PrEP adherence or relationship dynamics, with the exception of an increase in PrEP disclosure among intervention arm women. In our study, we cannot determine whether the lack of detectable findings may have been because of lack of intervention effect, strength of standard of care services, low risk in the study population, or other factors.

CONCLUSIONS

Addressing IPV and relationship dynamics remain important factors influencing HIV risk, and addressing these within the context of PrEP delivery is an important synergistic opportunity. CHARISMA was highly acceptable to participants, and further adaptation and testing of the intervention to other populations and settings will augment the evidence base.

摘要

背景

在女性中,一致使用口服暴露前预防(PrEP)一直是一个挑战,尤其是当她们与缺乏伴侣支持或亲密伴侣暴力(IPV)的关系时。

方法

我们在南非约翰内斯堡的 PrEP 示范项目中对一种名为“CHARISMA”的赋权咨询干预措施进行了一项随机对照试验(RCT)。该试验测试了 CHARISMA 增加 PrEP 依从性、减少社会危害和 IPV 以及改善伙伴关系动态(例如,沟通、披露和支持)的有效性,与接受标准护理咨询支持和转介的组相比。407 名 HIV 血清阴性、非孕妇年龄在 18-45 岁之间,接受了 6 个月的 PrEP 治疗,其中 203 名随机(1:1)接受干预。所有报告 IPV 的参与者都接受了咨询和转介,遵循了世界卫生组织的五步倾听、询问、验证、增强安全性和支持方法。

结果

这项 RCT 并没有发现研究组在 PrEP 依从性或关系动态方面存在统计学上的显著差异,除了干预组女性的 PrEP 披露有所增加。在我们的研究中,我们无法确定缺乏可检测到的发现是否是因为干预效果不足、标准护理服务的强度、研究人群的低风险或其他因素。

结论

解决 IPV 和关系动态仍然是影响 HIV 风险的重要因素,在 PrEP 提供的背景下解决这些问题是一个重要的协同机会。CHARISMA 受到参与者的高度欢迎,进一步对该干预措施进行调整和在其他人群和环境中的测试将增加证据基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验